Equity Profile

SNN

Smith & Nephew plc

Health CareHealth Care Equipment$13.0B

Feb6Thu

Pre-Earnings Brief

UpcomingQ3-2019Pre-Market9:00 AM EST

Company Snapshot

Smith & Nephew plc (SNN) is a global medical technology company specializing in advanced wound management, orthopedic reconstruction, and sports medicine. As a player in the health care equipment sector, it plays a crucial role in improving patient outcomes and enhancing the quality of care.

Key Metrics to Watch

Revenue Growth

This metric will indicate how well the company is expanding its sales, which is critical for assessing overall performance.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q3-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In Q2 2019, Smith & Nephew reported an EPS of $0.92, showing a positive trend compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's historical performance and recent stock movements.

Bull Case

If Smith & Nephew shows strong revenue growth and improved margins, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations on revenue or EPS, it may face a significant sell-off, especially given the high implied volatility in the options market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate for the advanced wound management segment?

This segment is crucial for the company's overall performance, and strong growth here could indicate successful product adoption.

How is Smith & Nephew managing its operating costs in the current economic environment?

Effective cost management will be vital for maintaining margins and profitability, especially if revenue growth is slower than expected.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for strong growth in the advanced wound management segment, which has been gaining traction.

Supporting Evidence

Historical data shows that Smith & Nephew has a 50% EPS beat rate, indicating potential upside.

Options pricing suggests a significant move, which may reflect investor sentiment that is more bullish than consensus estimates.

The lack of recent peer reports could mean that Smith & Nephew is not being compared accurately against its competitors.

Key Risk

If the advanced wound management segment shows unexpectedly high growth, it could challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued growth against the risks of economic headwinds affecting health care spending.

Bull Confirmed If

Revenue growth of over 10% year-over-year would confirm the bull case.

Bear Confirmed If

A decline in revenue or a significant miss on EPS would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±32.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±32.3% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

28.2%

Calls (300)P/C Ratio: 0.10Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.38% on the first day, confirming a positive outlook.

In-Line / Cautious

An in-line report could lead to a muted reaction, as the market digests management commentary and future guidance.

Miss

If the company misses expectations, history suggests a potential drop of about 1.11%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on product launches in the advanced wound management segment.
2Any commentary on the impact of economic conditions on sales.
3Details on cost management strategies and their effectiveness.
4Insights into market share changes in key segments.
5Future guidance on revenue and EPS expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Kennametal Inc.

Company Snapshot

Key Metrics to Watch

Revenue Growth

This metric will indicate how well the company is expanding its sales, which is critical for assessing overall performance.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q3-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In Q2 2019, Smith & Nephew reported an EPS of $0.92, showing a positive trend compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's historical performance and recent stock movements.

Bull Case

If Smith & Nephew shows strong revenue growth and improved margins, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations on revenue or EPS, it may face a significant sell-off, especially given the high implied volatility in the options market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate for the advanced wound management segment?

This segment is crucial for the company's overall performance, and strong growth here could indicate successful product adoption.

How is Smith & Nephew managing its operating costs in the current economic environment?

Effective cost management will be vital for maintaining margins and profitability, especially if revenue growth is slower than expected.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for strong growth in the advanced wound management segment, which has been gaining traction.

Supporting Evidence

Historical data shows that Smith & Nephew has a 50% EPS beat rate, indicating potential upside.

Options pricing suggests a significant move, which may reflect investor sentiment that is more bullish than consensus estimates.

The lack of recent peer reports could mean that Smith & Nephew is not being compared accurately against its competitors.

Key Risk

If the advanced wound management segment shows unexpectedly high growth, it could challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued growth against the risks of economic headwinds affecting health care spending.

Bull Confirmed If

Revenue growth of over 10% year-over-year would confirm the bull case.

Bear Confirmed If

A decline in revenue or a significant miss on EPS would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±32.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±32.3% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

28.2%

Calls (300)P/C Ratio: 0.10Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.38% on the first day, confirming a positive outlook.

In-Line / Cautious

An in-line report could lead to a muted reaction, as the market digests management commentary and future guidance.

Miss

If the company misses expectations, history suggests a potential drop of about 1.11%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on product launches in the advanced wound management segment.
2Any commentary on the impact of economic conditions on sales.
3Details on cost management strategies and their effectiveness.
4Insights into market share changes in key segments.
5Future guidance on revenue and EPS expectations.